811
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study

, , , , , & show all
Pages 29-36 | Published online: 14 Jan 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Marcus G. Tan, Whan B. Kim, Christine E. Jo, Karina Nabieva, Carly Kirshen & Arisa E. Ortiz. (2022) Topical treatment for postinflammatory hyperpigmentation: a systematic review. Journal of Dermatological Treatment 33:5, pages 2518-2526.
Read now
S. Saxena, R. M. Andersen & H. I. Maibach. (2015) Pitfalls in clinical trials reveal need for well tolerated, more effective depigmenting agents. Journal of Dermatological Treatment 26:5, pages 440-450.
Read now

Articles from other publishers (12)

Anita Damodaran & Nirmala Nair. 2023. Pigmentation Disorders - Etiology and Recent Advances in Treatments. Pigmentation Disorders - Etiology and Recent Advances in Treatments.
Dayoung Ko, Rebecca F. Wang, David Ozog, Henry W. Lim & Tasneem F. Mohammad. (2023) Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation. Journal of the American Academy of Dermatology 88:2, pages 291-320.
Crossref
Chensihui XIONG, Tianming DING, Jie LIU, Ou YI, Xiaoping DING & Yun XIE. (2022) Rapid determination of 22 functional components in cosmetics using ultra-high performance liquid chromatography-linear ion trap/orbitrap high resolution mass spectrometry. Chinese Journal of Chromatography 40:9, pages 817-824.
Crossref
Watinee Amornpetkul, Silada Kanokrungsee, Nanticha Kamanamool, Montree Udompataikul & Salinee Rojhirunsakool. (2021) Comparison between the use of intense pulsed light and Q‐switched neodymium‐doped yttrium aluminum garnet laser for the treatment of axillary hyperpigmentation. Journal of Cosmetic Dermatology 20:9, pages 2785-2793.
Crossref
Yong Chool Boo. (2021) Mechanistic Basis and Clinical Evidence for the Applications of Nicotinamide (Niacinamide) to Control Skin Aging and Pigmentation. Antioxidants 10:8, pages 1315.
Crossref
Jun-Young Park, Hyun-Ju Choi, Tamina Park, Moon-Jo Lee, Hak-Seong Lim, Woong-Suk Yang, Cher-Won Hwang, Daeui Park & Cheorl-Ho Kim. (2021) Inhibitory Effect of Avenanthramides (Avn) on Tyrosinase Activity and Melanogenesis in α-MSH-Activated SK-MEL-2 Cells: In Vitro and In Silico Analysis. International Journal of Molecular Sciences 22:15, pages 7814.
Crossref
Daniel L. KrinskyKatherine S. O’Neal. 2020. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 20th Edition. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 20th Edition.
Seung-Hwa Baek, Myung-Gyun Kang & Daeui Park. (2020) Inhibitory Effect of Sesamolin on Melanogenesis in B16F10 Cells Determined by In Vitro and Molecular Docking Analyses. Current Pharmaceutical Biotechnology 21:2, pages 169-178.
Crossref
Miriam Sonnet. (2019) Neue Therapien der Hyperpigmentierung am Horizont?. ästhetische dermatologie & kosmetologie 11:5, pages 10-15.
Crossref
Jihea Yang & Bumsang Kim. (2018) Synthesis and characterization of ethosomal carriers containing cosmetic ingredients for enhanced transdermal delivery of cosmetic ingredients. Korean Journal of Chemical Engineering 35:3, pages 792-797.
Crossref
Suteeraporn Chaowattanapanit, Narumol Silpa-archa, Indermeet Kohli, Henry W. Lim & Iltefat Hamzavi. (2017) Postinflammatory hyperpigmentation: A comprehensive overview. Journal of the American Academy of Dermatology 77:4, pages 607-621.
Crossref
Narumol Silpa-archa, Indermeet Kohli, Suteeraporn Chaowattanapanit, Henry W. Lim & Iltefat Hamzavi. (2017) Postinflammatory hyperpigmentation: A comprehensive overview. Journal of the American Academy of Dermatology 77:4, pages 591-605.
Crossref